pubmed-article:1535214 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1535214 | lifeskim:mentions | umls-concept:C0022567 | lld:lifeskim |
pubmed-article:1535214 | lifeskim:mentions | umls-concept:C0035339 | lld:lifeskim |
pubmed-article:1535214 | lifeskim:mentions | umls-concept:C1293122 | lld:lifeskim |
pubmed-article:1535214 | lifeskim:mentions | umls-concept:C1819436 | lld:lifeskim |
pubmed-article:1535214 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
pubmed-article:1535214 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:1535214 | pubmed:dateCreated | 1992-7-27 | lld:pubmed |
pubmed-article:1535214 | pubmed:abstractText | The effect of retinoids on the production of interleukin-1 (IL-1) by murine epidermal keratinocytes was investigated. Freshly isolated keratinocytes were cultured in the presence of etretinate, acitretin, all-trans retinoic acid or 13-cis retinoic acid at concentrations of 8 x 10(-9)-8 x 10(-6) mol/l. Exposure of keratinocytes to retinoids increased IL-1 bioactivity in culture supernatants and cell extracts at concentrations as low as 8 x 10(-9) mol/l, as assessed by T-cell proliferation. Prolongation of the culture period enhanced the augmentative effect of retinoids. All-trans retinoic acid and 13-cis retinoic acid had a greater ability to induce IL-1 production than the two aromatic retinoids, etretinate and acitretin. Treatment with 8-methoxypsoralen plus ultraviolet A radiation and treatment with triamcinolone acetonide both reduced the effect of retinoids on the production of bioactive IL-1. | lld:pubmed |
pubmed-article:1535214 | pubmed:language | eng | lld:pubmed |
pubmed-article:1535214 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1535214 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1535214 | pubmed:month | May | lld:pubmed |
pubmed-article:1535214 | pubmed:issn | 0007-0963 | lld:pubmed |
pubmed-article:1535214 | pubmed:author | pubmed-author:EdelsonR LRL | lld:pubmed |
pubmed-article:1535214 | pubmed:author | pubmed-author:TokuraYY | lld:pubmed |
pubmed-article:1535214 | pubmed:author | pubmed-author:GasparroF PFP | lld:pubmed |
pubmed-article:1535214 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1535214 | pubmed:volume | 126 | lld:pubmed |
pubmed-article:1535214 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1535214 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1535214 | pubmed:pagination | 485-95 | lld:pubmed |
pubmed-article:1535214 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:meshHeading | pubmed-meshheading:1535214-... | lld:pubmed |
pubmed-article:1535214 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1535214 | pubmed:articleTitle | Retinoid augmentation of bioactive interleukin-1 production by murine keratinocytes. | lld:pubmed |
pubmed-article:1535214 | pubmed:affiliation | Department of Dermatology, Yale University School of Medicine, New Haven. | lld:pubmed |
pubmed-article:1535214 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1535214 | lld:pubmed |